Qube Research & Technologies Ltd increased its stake in Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) by 86.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,525 shares of the medical equipment provider's stock after acquiring an additional 9,069 shares during the quarter. Qube Research & Technologies Ltd owned 0.29% of Semler Scientific worth $968,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of SMLR. Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $10,898,000. Invenire Partners LP acquired a new position in shares of Semler Scientific during the fourth quarter valued at about $4,456,000. Anchor Capital Advisors LLC acquired a new position in shares of Semler Scientific during the first quarter valued at about $1,573,000. Adirondack Retirement Specialists Inc. increased its position in shares of Semler Scientific by 59.4% during the first quarter. Adirondack Retirement Specialists Inc. now owns 48,933 shares of the medical equipment provider's stock worth $2,546,000 after acquiring an additional 18,226 shares in the last quarter. Finally, Dimensional Fund Advisors LP bought a new stake in shares of Semler Scientific during the fourth quarter worth about $1,552,000. Institutional investors and hedge funds own 44.69% of the company's stock.

Analysts Set New Price Targets

Separately, B. Riley decreased their target price on shares of Semler Scientific from $70.00 to $60.00 in a research report on Tuesday, May 3rd.

Semler Scientific Stock Down 2.5 %

Semler Scientific Company Profile

(Get Rating)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Recommended Stories

• Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
• Which Semiconductor Stocks Are Ready For Big Price Moves?
• Miners Advance On Earnings Despite Broader Economic Challenges
• Lowe's Stands Out Amid Q2 Retail Reports
• Agilent Technologies Proves Its Worth VS Illumina
• Target's Results Cap Upside Potential For Retail Stocks

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.